Up to now, studies that interrogate the cellular and molecular mechanisms that govern dysregulated CRC lipid metabolism and its effect on the immune tumour microenvironment (TME) are incredibly restricted.mRNA was significantly downregulated in colon tumours versus matched normal controls (n=fifty five?for every group, *pBeneficial microbes can als